Trial Profile
Multicentre, cohort study to evaluate the survival in caucasian chronic hepatitis B patients with or without cirrhosis who are undergoing long term therapy with entecavir or tenofovir
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 11 Aug 2015 New trial record